Related Experiment Video
Updated: Jul 4, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting
Patricia W Lin1, Tala R Nasr, Andrew J Berardinelli
1Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, USA. Patricia_Lin@oz.ped.emory.edu
Insights
Probiotics like Lactobacillus rhamnosus GG (LGG) reduce intestinal epithelial apoptosis in preterm infants. LGG stimulates antiapoptotic and cytoprotective genes, potentially preventing necrotizing enterocolitis (NEC).
Area of Science:
- Gastroenterology
- Neonatology
- Microbiology
Background:
- Necrotizing enterocolitis (NEC) is a major cause of illness and death in preterm infants.
- Inappropriate apoptosis of mucosal epithelia is a suspected factor in NEC development.
- Probiotics show promise in reducing NEC incidence and suppressing intestinal cell apoptosis.
Purpose of the Study:
- To investigate the in vivo mechanism of probiotic Lactobacillus rhamnosus GG (LGG) in modulating intestinal epithelial apoptosis.
- To confirm LGG's antiapoptotic effects in the developing intestine.
- To identify molecular pathways influenced by LGG in vivo.
Main Methods:
- In vitro confirmation of LGG's ability to reduce chemically induced intestinal epithelial apoptosis.
- Oral administration of LGG to live animals, followed by ex vivo apoptosis measurement (caspase 3, TUNEL staining).
- cDNA microarray analysis of intestinal tissue from LGG-treated mice to assess gene expression.
Main Results:
- LGG effectively reduced chemically induced intestinal epithelial apoptosis in vitro.
- Oral LGG administration in vivo decreased chemically induced apoptosis ex vivo.
- LGG up-regulated multiple cytoprotective and antiapoptotic genes in the mouse intestine.
Conclusions:
- Probiotics like LGG can enhance intestinal defenses in the developing gut by promoting antiapoptotic and cytoprotective responses.
- Understanding how probiotics affect apoptotic pathways is crucial for developing targeted NEC therapies.
- LGG demonstrates potential as a preventive strategy against NEC by modulating epithelial cell apoptosis.
Abstract:
Necrotizing enterocolitis (NEC) remains a leading cause of morbidity and mortality in preterm infants. Although its pathogenesis is poorly understood, inappropriate apoptosis of the mucosal epithelia has been implicated. Recent clinical trials have shown that probiotics may reduce the incidence of NEC, and probiotics have been shown to suppress intestinal epithelial apoptosis in cultured cells. However, little is known about their mechanism of action in the developing intestine in vivo. Here, we confirm that the probiotic Lactobacillus rhamnosus GG (LGG) reduces chemically induced intestinal epithelial apoptosis in vitro. Furthermore, we report for the first time that LGG administered orally to live animals can reduce chemically induced epithelial apoptosis ex vivo, as measured by staining for active caspase 3 and terminal deoxynucleotidyltransferase. Using cDNA microarray analysis from the intestine of live, orally inoculated mice, we show that LGG up-regulates a battery of genes with known and likely cytoprotective effects. These studies indicate that probiotics such as LGG may augment intestinal host defenses in the developing intestine by stimulating antiapoptotic and cytoprotective responses. Because apoptosis may be a precursor to NEC, understanding the mechanism behind probiotic modulation of apoptotic pathways may allow for development of more specifically targeted therapies or preventive strategies in the future.
Related Concept Videos
Probiotics
Functions of the Gut Microbiota
Microbiota Modulation by Antibiotics
Microbiota of the Stomach and Small Intestine
Development of Human Microbiota
Dysbiosis of the Gut Microbiota

